R&D - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe
R&D

Pfizer Restructuring a Boon to CMOs and CROs

March 2, 2007
By: Jim Miller
Pharmaceutical Technology

As big pharmaceutical companies restructure and reevaluate the way they do business, contract research and manufacturing organizations could reap greater financial rewards.

Will Delivery Technologies Deliver Profits to CMOs?...

October 2, 2006
By: Jim Miller
Special from Pharmaceutical Technology

More CMOs look to proprietary delivery technologies to enhance profitability.

First Impressions...

July 2, 2006
By: Jim Miller
Special from Pharmaceutical Technology

China is on the rise as a center for pharmaceutical R&D, but companies are still getting their footing for operating in China and the services industry has some maturing to do.

Here's to a Strong 2006!

January 1, 2006
By: Jim Miller
Pharmaceutical Technology

The big question for pharmaceutical services providers coming into 2006 is: will the good times continue to roll?

Compounding Pharmacies' Lawsuit Against FDA Will Continue

May 27, 2005
Pharmaceutical Technology

Compounding Pharmacies' Lawsuit Against FDA Will Continue

Outsourcing Outlook

June 1, 2002
By: Jim Miller
Pharmaceutical Technology

The author discusses the upcoming human research congressional debate and CROs' preparations to respond.

ADVERTISEMENT
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
21%
To all process for new products only
13%
To select process for new products only
26%
To select processes for both new and legacy products
21%
Do not use QbD
21%
View Results
Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
FindPharma Custom Search
Featured Jobs

More Jobs
Click here